Get startedLog in
    Picture of Percheron Therapeutics logo

    PER — Percheron Therapeutics News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    All News

    Brief: Antisense Therapeutics Says FY Net Loss Attributable A$5.8 Million

    Picture of Percheron Therapeutics logoPercheron Therapeutics
    31/08/2022 08:01
    Aug 31 (Reuters) - Antisense Therapeutics Ltd  ANP.AX :
    * FY NET LOSS ATTRIBUTABLE A$5.8 MILLION


Further company coverage:  ANP.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Percheron Therapeutics

    See all news